Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRR1 | P24046 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | HRH4 | Q9H3N8 | 4/20 | 0.39 |
| ▸ | HRH3 | Q9Y5N1 | 4/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | GLA | P06280 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
| ▸ | THPO | P40225 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | APEX1 | P27695 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | GDA | Q9Y2T3 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11411483 | 0.77 | GABRR1 (0.37) | GABRR1KDM4EBLMGDACYP2C19 | |
| SCHEMBL11389117 | 0.77 | KDM4E (0.49) | GABRR1KDM4EHRH4HRH3ALDH1A1 | |
| Hydrochloric Acid SCHEMBL947746 | 0.75 | KDM4E (0.47) | GABRR1KDM4EALDH1A1MEN1KMT2A | |
| SCHEMBL2790547 | 0.73 | GABRR1 (0.61) | GABRR1KDM4EALDH1A1CYP1A2NFKB1 | |
| SCHEMBL23930811 | 0.73 | GABRR1 (0.43) | GABRR1KDM4EALDH1A1LMNAGDA | |
| SCHEMBL2627830 | 0.69 | KDM4E (0.41) | GABRR1KDM4EALDH1A1MEN1KMT2A | |
| SCHEMBL18599226 | 0.67 | GDA (0.40) | GABRR1KDM4EALDH1A1LMNAGDA | |
| SCHEMBL2815970 | 0.67 | GABRR1 (0.57) | GABRR1HRH4HRH3ALDH1A1MEN1 | |
| SCHEMBL2815963 | 0.67 | GABRR1 (0.57) | GABRR1HRH4HRH3ALDH1A1MEN1 | |
| SCHEMBL101340 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 135 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230116385-A1 | COMPOSITION OF A THERAPEUTIC OLIGOMER | Sachi Bioworks Inc. (US) | 2023-04-13 | — | — | US | disclosed |
| US-11155631-B2 | Macromolecular compositions that cross the blood-brain barrier and methods of use thereof | ARMAGEN, INC. (US) | 2021-10-26 | — | — | US | disclosed |
| CN-112730695-A | Method for measuring content of amino acid in fresh tobacco leaves | 云南中烟工业有限责任公司 | 2021-04-30 | — | — | CN | disclosed |
| US-10144783-B2 | Macromolecular compositions that cross the blood-brain barrier and methods of use thereof | ARMAGEN, INC. (US) | 2018-12-04 | — | — | US | disclosed |
| EP-2051734-B1 | AGENTS FOR BLOOD-BRAIN BARRIER DELIVERY | ARMAGEN TECHNOLOGIES INC (US) | 2016-10-05 | — | — | EP | disclosed |
| US-9315851-B2 | Methods, peptides, and biosensors useful for detecting a broad spectrum of bacteria | WOUNDCHEK LABORATORIES (US), INC. (US) | 2016-04-19 | — | — | US | disclosed |
| EP-2255826-B1 | NEISSERIAL VACCINE COMPOSITIONS COMPRISING A COMBINATION OF ANTIGENS | GLAXOSMITHKLINE BIOLOG SA (BE) | 2016-04-13 | — | — | EP | disclosed |
| US-20160082097-A1 | NEISSERIAL VACCINE COMPOSITIONS COMPRISING A COMBINATION OF ANTIGENS | GLAXOSMITHKLINE BIOLOG SA (BE) | 2016-03-24 | — | — | US | disclosed |
| US-20150203586-A1 | MACROMOLECULAR COMPOSITIONS THAT CROSS THE BLOOD-BRAIN BARRIER AND METHODS OF USE THEREOF | ARMAGEN, INC. | 2015-07-23 | — | — | US | disclosed |
| US-20150184220-A1 | Methods, Peptides, and Biosensors Useful for Detecting a Broad Spectrum of Bacteria | WOUNDCHEK LAB US INC (US) | 2015-07-02 | — | — | US | disclosed |
| EP-1078063-A2 | BASB029POLYNUCLEOTIDE(S) AND POLYPEPTIDES FROM NEISSERIA MENINGITIS | SmithKline Beecham Biologicals s.a. (BE) | 2001-02-28 | — | — | EP | disclosed |
| EP-1073747-A1 | BASB013 DNA AND PROTEINS FROM NEISSERIA MENINGITIDIS | SMITHKLINE BEECHAM BIOLOGICALS s.a. (BE) | 2001-02-07 | — | — | EP | disclosed |
| EP-1071783-A2 | BASB006 POLYNUCLEOTIDE(S) AND POLYPEPTIDES FROM NEISSERIA MENINGITIS | SMITHKLINE BEECHAM BIOLOGICALS s.a. (BE) | 2001-01-31 | — | — | EP | disclosed |
| WO-2000015801-A1 | POLYNUCLEOTIDES AND POLYPEPTIDES BASB033 FROM NEISSERIA MENINGITIDIS AND THEIR USES | SMITHKLINE BEECHAM BIOLOGICALS S.A. (BE) | 2000-03-23 | — | — | WO | disclosed |
| WO-2000011182-A1 | BASB024 OUTER MEMBRANE PROTEIN OF NEISSERIA MENINGITIDIS | SMITHKLINE BEECHAM BIOLOGICALS S.A. (BE) | 2000-03-02 | — | — | WO | disclosed |
| WO-1999061620-A2 | NEISSERIA MENINGITIDIS ANTIGENIC POLYPEPTIDES, CORRESPONDING POLYNUCLEOTIDES AND PROTECTIVE ANTIBODIES | SMITHKLINE BEECHAM BIOLOGICALS S.A. (BE) | 1999-12-02 | — | — | WO | disclosed |
| WO-1999058683-A2 | BASB029 POLYNUCLEOTIDE(S) AND POLYPEPTIDES FROM $i(NEISSERIA MENINGITIDIS) | SMITHKLINE BEECHAM BIOLOGICALS S.A. (BE) | 1999-11-18 | — | — | WO | disclosed |
| WO-1999055872-A1 | BASB013 DNA AND PROTEINS FROM NEISSERIA MENINGITIDIS | SMITHKLINE BEECHAM BIOLOGICALS S.A. (BE) | 1999-11-04 | — | — | WO | disclosed |
| WO-1999055873-A2 | BASB006 POLYNUCLEOTIDE(S) AND POLYPEPTIDES FROM NEISSERIA MENINGITIS | SMITHKLINE BEECHAM BIOLOGICALS S.A. (BE) | 1999-11-04 | — | — | WO | disclosed |
| CN-1182432-A | Human neuropeptide receptor | HUMAN GENOME SCIENCES INC (US) | 1998-05-20 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160082097-A1 | NEISSERIAL VACCINE COMPOSITIONS COMPRISING A COMBINATION OF ANTIGENS | NASP, SPAG5, ANTXR2 | GABRR1 3363/4885KDM4E 4458/4885HRH4 4431/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.